Skip to main content
. 2023 May 18;14:1136343. doi: 10.3389/fimmu.2023.1136343

Table 2.

The characteristics of FMT in these included RCTs.

Trial ID Intervening measure Route of FMT
(position)
Frequency
of FMT
Number
of donor
Style of stools Dose of stool Effective for IBS
FMT placebo
NCT02299973 non-capsule FMT autologous stools nasojejunal tube (jejunum) single,
second
2 fresh, from 1 donor no report Yes
NCT02788071 capsule FMT placebo capsules oral capsules
(stomach)
12 days 4 frozen, mixed 600g
(50g/day×12 days)
No
NCT03822299 non-capsule FMT autologous stools gastroscope
(distal duodenum)
single 1 frozen, from 1 donor 30g/60g Yes
NCT03561519 non-capsule FMT autologous stools colonoscopy
(caecum)
single 1 frozen, from 1 donor 30g Yes
NCT02154867 non-capsule FMT autologous stools colonoscopy
(caecum)
single 2 fresh/frozen, mixed 50-80g Yes
NCT02328547 capsule FMT placebo capsules oral capsules
(stomach)
3 days 4 frozen, from 1 donor 28.5g
(9.5g/day×3 days)
No
NCT02092402 non-capsule FMT autologous stools colonoscopy
(caecum)
single 2 frozen, from 1 donor 30g Yes
NCT02847481 capsule FMT placebo capsules oral capsules
(stomach)
1 day 6 frozen, mixed 14.25g
(14.25g/d×1day)
No
ChiCTR1900024924 capsule FMT placebo capsules oral capsules
(stomach)
3 days 1 frozen, from 1 donor no report
(30 capsules/day×3 days)
Yes

NCT, national clinical trial; FMT, fecal microbiota transplantation; M, male; F, female; IBS-SSS, irritable bowel syndrome severity scoring system; IBS-QoL, irritable bowel syndrome specific quality of life.